Announcement of TTY Biopharm's unaudited income information in September 2022
2022.10.11
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2022/10/11 | Time of announcement | 14:19:19 |
| Subject | Announcement of TTY Biopharm's unaudited income information in September 2022 | ||||
| Date of events | 2022/10/11 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2022/10/11 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $531,569 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $171,347 thousands, and a consolidated income before tax of $209,202 thousands in September 2022; net income attributed to stockholders of the company was $159,955 thousands; EPS is $0.64. Year-to-date consolidated net sales was $3,528,806 thousands (in NT dollars; unaudited), a consolidated operating profit was $913,306 thousands and consolidated income before tax was $1,081,058 thousands until September 2022; year-to-date net income attributed to stockholders of the company was $855,521 thousands; EPS is $3.44. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||